LENZ Therapeutics Inc (LENZ) — Financial Flexibility Index
LENZ Therapeutics Inc (LENZ) has a Financial Flexibility Index of -1.53x as of December 2025. Free cash flow of $-32.99 Million (operating CF $-33.02 Million minus capex $38.00K) represents -2% of total liabilities ($21.54 Million). Check LENZ asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LENZ Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for LENZ Therapeutics Inc across 7 annual periods. See working capital position of LENZ Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for LENZ Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for LENZ Therapeutics Inc. For the full company profile including market capitalisation, see market value of LENZ Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.17x | $-68.34 Million | $-69.17 Million | $21.54 Million | ▲ +39.6% |
| 2024 | -5.25x | $-58.92 Million | $-59.39 Million | $11.22 Million | ▼ -1319.2% |
| 2023 | -0.37x | $-60.35 Million | $-60.38 Million | $163.09 Million | ▲ +67.7% |
| 2022 | -1.14x | $-81.39 Million | $-87.98 Million | $71.12 Million | ▲ +20.9% |
| 2021 | -1.45x | $-47.11 Million | $-52.85 Million | $32.55 Million | ▼ -552.8% |
| 2020 | -0.22x | $-7.18 Million | $-8.72 Million | $32.36 Million | ▼ -2495.4% |
| 2019 | -0.01x | $-19.00K | $-19.00K | $2.22 Million | — |